Dexmedetomidine + Propofol for Pediatric Sedation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the safest way to sedate young children during MRI scans using a combination of dexmedetomidine and propofol. Researchers aim to determine if adding dexmedetomidine can reduce the required amount of propofol and how this approach affects recovery time post-procedure. The trial includes different groups testing various doses to identify the most effective option without causing additional side effects. Children aged 1 to 12 undergoing an MRI of the brain, body, or limbs who can use a natural airway may be suitable candidates for this trial. As a Phase 4 trial, this research seeks to understand how the already FDA-approved sedation method can benefit more patients.
Will I have to stop taking my current medications?
If you are taking digoxin, beta-blockers, anxiolytics like midazolam or ketamine, or certain other medications like alpha-adrenergic or beta-adrenergic drugs, you will need to stop taking them to participate in this trial.
What is the safety track record for dexmedetomidine and propofol?
Research has shown that combining dexmedetomidine with propofol for sedation in children might be safer than using propofol alone. One study found that this combination reduced the risk of breathing problems, which often occur with propofol alone. Another study discovered that dexmedetomidine might slightly delay waking after a procedure compared to propofol alone, but the difference was not significant.
Dexmedetomidine is already approved for use in intensive care, indicating it is generally considered safe for sedation. While adding dexmedetomidine might slightly extend recovery time, it could also reduce breathing issues during sedation.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about combining dexmedetomidine with propofol for pediatric sedation because it offers a potentially safer and more effective sedation method compared to using propofol alone. Unlike the standard practice of using propofol, which can cause cardiovascular and respiratory issues at high doses, adding dexmedetomidine may allow for reduced propofol doses while maintaining effective sedation. Dexmedetomidine has a unique mechanism of action, providing sedation without heavy respiratory depression and offering additional analgesic effects. This combination could lead to fewer side effects and better overall patient comfort during procedures.
What evidence suggests that this trial's treatments could be effective for pediatric sedation during MRI?
This trial will compare different sedation approaches for pediatric patients. Research has shown that a mix of dexmedetomidine and propofol can effectively keep children calm during an MRI scan. In this trial, participants may receive either propofol alone or the combination of dexmedetomidine and propofol. Studies have found this combination to be highly successful, with almost all children achieving the needed level of calmness. Dexmedetomidine reduces the amount of propofol needed, potentially lowering the chance of side effects. It may also lessen the risk of breathing problems associated with propofol alone. Although concerns exist about longer recovery times, using smaller amounts of dexmedetomidine might not significantly delay recovery. Overall, this combination appears promising for safe and effective sedation in children.24567
Who Is on the Research Team?
Joseph Cravero, MD
Principal Investigator
Boston Children's Hospital
Are You a Good Fit for This Trial?
This trial is for children aged 1-12 who need sedation for an MRI scan. They should be healthy or have mild systemic disease (ASA I, II, III) and can breathe on their own during the procedure. It's not suitable for kids who aren't fit for the described sedation method.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive sedation with either Propofol only or Dexmedetomidine-Propofol combination for MRI scans
Post-Anesthesia Recovery
Participants are monitored in the PACU for recovery and adverse events
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dexmedetomidine
- Propofol
Trial Overview
The study compares different doses of Propofol alone versus a combination of Dexmedetomidine and Propofol in pediatric patients undergoing MRI to find the best balance between effective sedation and quick recovery without increasing neurotoxic risks.
How Is the Trial Designed?
3
Treatment groups
Active Control
If randomized to the P arm, the patient will receive a 2-4 mg/kg titrated IV bolus of propofol until sleep is induced. 250 mcg/kg/min infusion of IV propofol will then be started.
If randomized to the DHP arm, patient will receive an IV bolus of 1 mcg/kg of dexmedetomidine followed by a 1-2 mg/kg titrated IV bolus of propofol until sleep. 150 mcg/kg/min infusion of IV propofol will then be started. If not sedated within 10 minutes: 1-2 mg/kg bolus of propofol. If not sedated within 2 more minutes: 1-2 mg/kg bolus of propofol and increase propofol infusion to 200 mcg/kg/min (Can be titrated up to a maximum of 300 mcg/kg/min). If not sedated after 5 more minutes, record a technique failure and continue sedation at anesthesiologist's discretion.
If randomized to the DLP arm, patient will receive an IV bolus of 0.5 mcg/kg of dexmedetomidine followed by a 1-2 mg/kg titrated IV bolus of propofol until sleep. 150 mcg/kg/min infusion of IV propofol will then be started. If not sedated within 10 minutes: 1-2 mg/kg bolus of propofol. If not sedated within 2 more minutes: 1-2 mg/kg bolus of propofol and increase propofol infusion to 200 mcg/kg/min (Can be titrated up to a maximum of 300 mcg/kg/min). If not sedated after 5 more minutes, record a technique failure and continue sedation at anesthesiologist's discretion.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor
Citations
Intranasal Dexmedetomidine with Propofol Provides Superior ...
Sedation onset was faster with D-P (median 17 vs 20 minutes, P < 0.001), with 98.2% achieving sleep within 20 minutes versus 54.5% for D-M.
Dexmedetomidine versus propofol on the sedation of ...
The pooling data showed that propofol had a shorter onset of sedation time (WMD: 6.05, 95% CI: 3.12–8.98, P < 0.0001) (Figure 2) and recovery ...
3.
rethinkingclinicaltrials.org
rethinkingclinicaltrials.org/news/grand-rounds-august-15-2025-dexmedetomidine-or-clonidine-based-sedation-compared-with-propofol-in-critically-ill-patients-the-a2b-randomized-clinical-trial-addressing-a-complex-clinical/or Clonidine-Based Sedation Compared With Propofol in ...
Dexmedetomidine is licensed for ICU sedation and is believed to achieve a lighter level of sedation compared with propofol, but has a higher ...
Propofol Versus Dexmedetomidine for Procedural ...
Propofol and dexmedetomidine resulted in successful completion of the study in 98.8% and 99.7%, respectively (P = 0.02). The mean recovery time for propofol was ...
Dexmedetomidine and Propofol for Pediatric MRI Sedation
The purpose of this study is to compare the results of combining two anesthetic medications (dexmedetomidine and propofol) in low doses with a standard dose ...
6.
dovepress.com
dovepress.com/intranasal-dexmedetomidine-with-propofol-provides-superior-sedation-fo-peer-reviewed-fulltext-article-DDDTIntranasal Dexmedetomidine with Propofol Provides ...
Combination with intranasal dexmedetomidine decreases the risk of adverse airway events compared to intravenous propofol alone for pediatric ...
Clinical efficacy of dexmedetomidine versus propofol in ... - PMC
Compared with propofol group, dexmedetomidine significantly increased the recovery time (WMD: 10.70 min; 95% CI: 4.26-17.13; P = 0.001). The duration of ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.